- Home
- ISPR vs NKTR Comparison
ISPR vs NKTR Comparison
Compare ISPR & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ISPR
- NKTR
- Stock Information
- Founded
- ISPR 2019
- NKTR 1990
- Country
- ISPR United States
- NKTR United States
- Employees
- ISPR N/A
- NKTR N/A
- Industry
- ISPR Medicinal Chemicals and Botanical Products
- NKTR Biotechnology: Pharmaceutical Preparations
- Sector
- ISPR Health Care
- NKTR Health Care
- Exchange
- ISPR Nasdaq
- NKTR Nasdaq
- Market Cap
- ISPR 152.0M
- NKTR 125.5M
- IPO Year
- ISPR 2023
- NKTR 1994
- Fundamental
- Price
- ISPR $2.47
- NKTR $8.51
- Analyst Decision
- ISPR Strong Buy
- NKTR Strong Buy
- Analyst Count
- ISPR 2
- NKTR 6
- Target Price
- ISPR $10.00
- NKTR $73.75
- AVG Volume (30 Days)
- ISPR 42.5K
- NKTR 348.5K
- Earning Date
- ISPR 05-12-2025
- NKTR 08-07-2025
- Dividend Yield
- ISPR N/A
- NKTR N/A
- EPS Growth
- ISPR N/A
- NKTR N/A
- EPS
- ISPR N/A
- NKTR N/A
- Revenue
- ISPR $144,700,345.00
- NKTR $87,248,000.00
- Revenue This Year
- ISPR N/A
- NKTR N/A
- Revenue Next Year
- ISPR $35.39
- NKTR N/A
- P/E Ratio
- ISPR N/A
- NKTR N/A
- Revenue Growth
- ISPR N/A
- NKTR N/A
- 52 Week Low
- ISPR $2.36
- NKTR $6.48
- 52 Week High
- ISPR $8.13
- NKTR $22.79
- Technical
- Relative Strength Index (RSI)
- ISPR 41.12
- NKTR 42.19
- Support Level
- ISPR $2.36
- NKTR $7.99
- Resistance Level
- ISPR $2.62
- NKTR $9.71
- Average True Range (ATR)
- ISPR 0.17
- NKTR 1.37
- MACD
- ISPR 0.00
- NKTR -0.20
- Stochastic Oscillator
- ISPR 22.45
- NKTR 11.66
About ISPR Ispire Technology Inc.
Ispire Technology Inc is engaged in the research and development, design, commercialization, sales, marketing, and distribution of branded e-cigarettes and cannabis vaping products. The company sells its cannabis vaping in the United States, Europe, Canada, and South Africa.
About NKTR Nektar Therapeutics
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.